Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC charges weight-loss product marketers

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission underscores that dietary supplement weight-loss claims are a top enforcement priority by charging three companies and two individuals with making false claims for diet products Relacore and Akavar 20/50. The commission seeks restitution from Basic Research, Carter-Reed, Dynakor Pharmacal and company executives Dennis Gay and Mitchell Friedlander. The suit, filed in U.S. District Court for the District of Utah, also alleges Basic Research, Gay and Friedlander violated a previous order from 2006 not to make bogus claims. The violation occurred when they advertised Relacore and Akavar as allowing users to "eat all you want and still lose weight." The case drives home the message David Vladeck, director of the Bureau of Consumer Protection, delivered in July when he said supplement weight-loss claims are a "high priority" for FTC because "false claims engender false hopes" (1"The Tan Sheet" Aug. 3, 2009)

The Federal Trade Commission underscores that dietary supplement weight-loss claims are a top enforcement priority by charging three companies and two individuals with making false claims for diet products Relacore and Akavar 20/50 . The commission seeks restitution from Basic Research, Carter-Reed, Dynakor Pharmacal and company executives Dennis Gay and Mitchell Friedlander. The suit, filed in U.S. District Court for the District of Utah, also alleges Basic Research, Gay and Friedlander violated a previous order from 2006 not to make bogus claims. The violation occurred when they advertised Relacore and Akavar as allowing users to "eat all you want and still lose weight." The case drives home the message David Vladeck, director of the Bureau of Consumer Protection, delivered in July when he said supplement weight-loss claims are a "high priority" for FTC because "false claims engender false hopes" (1 'The Tan Sheet' Aug. 3, 2009).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel